RBMY2HP

Across TCGA pan-cancer cohorts, RBMY2HP RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RBMY2HP data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RBMY2HP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RBMY2HP expression acts as an unfavorable survival marker, although some lineages such as BLCA and GBM show a favorable association.

MESO, OV, and BLCA are the cancer types where RBMY2HP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	III,IV	0.121	0.427	<.001	108	view →
OV	OS	Tertile	II,III,IV	0.048	0.844	<.001	108	view →
BLCA	OS	Tertile	II,III,IV	0.874	0.407	.011	72	view →
COAD	OS	Tertile	II,III,IV	0.145	0.853	<.001	72	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	36	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	36	view →
STAD	OS	Tertile	All	0.142	0.730	<.001	18	view →
PAAD	OS	Tertile	II,III,IV	0.300	0.587	.038	18	view →
LUAD	OS	Tertile	All	0.211	0.697	.005	18	view →
SARC	OS	Tertile	All	0.183	0.827	<.001	18	view →
LIHC	OS	Tertile	III,IV	0.403	0.653	.045	15	view →
LGG	DFS	Tertile	All	0.467	0.831	.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RBMY2HP–MESO (DFS)

Open the MESO breakdown →